title: Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment.
authors.affiliation: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Room 108, 1550 Orleans St, Baltimore, MD 21231, USA.|Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.|Howard Hughes Medical Institute, Chevy Chase, MD, USA.
authors.forename: Geetha
authors.initials: G
authors.lastname: Srikrishna
authors.affiliation: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Room 108, 1550 Orleans St, Baltimore, MD 21231, USA.|Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.|Howard Hughes Medical Institute, Chevy Chase, MD, USA.
authors.forename: Shashank
authors.initials: S
authors.lastname: Gupta
authors.affiliation: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Room 108, 1550 Orleans St, Baltimore, MD 21231, USA.|Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.|Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Kelly E
authors.initials: KE
authors.lastname: Dooley
authors.affiliation: Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Room 108, 1550 Orleans St, Baltimore, MD 21231, USA.|Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.|Howard Hughes Medical Institute, Chevy Chase, MD, USA.
authors.forename: William R
authors.initials: WR
authors.lastname: Bishai
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D064687:Diarylquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000628:therapy*; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D000995:Antitubercular Agents; D064687:Diarylquinolines; C493870:bedaquiline; D014700:Verapamil
keywords: adjunctive therapy; bedaquiline; cardiotoxicity; drug-resistant tuberculosis; verapamil